Introduction
There are many disease processes that affect only the white matter or predominantly affect the white matter more than the gray matter. The etiologies of WMDs (white matter diseases) are numerous and varied; and, multiple classification systems have been used. The most common classification divides WMDs into two large categories: Demyelination -loss of previously normal myelinated white matter (WM); and, Dysmyelination -defective metabolism and maintenance of WM.
Dysmyelinating syndromes are usually genetic defects in metabolism and are therefore congenital. Most are present in infancy or early childhood, although some may have a delayed clinical onset due to abnormal accumulation of myelin by-products. In contrast, demyelination is acquired and may be infectious, inflammatory or auto-immune, toxic or metabolic, and vascular or age-related. This presentation will review the radiologic-pathologic correlation of several common and important white matter diseases.
Understanding of the pathology can illuminate our understanding of the WMD appearance on Neuroimaging and improve differential diagnosis.
Multiple Sclerosis
Multiple sclerosis (MS) is the most common, best known, and most extensively studied of the WMDs. Despite that, the etiology of MS continues to elude definitive explanation. In addition to four generally accepted clinical variants of MS (table 1) -four pathophysiologic variants have been described, called Lassmann patterns. (table 2) . The variety in both clinical and pathologic description continues to suggest that MS is a "family of diseases" rather than a single pathologic entity. stain. There are intact "naked" neurons -no myelin staining is noted. B) Photomicrograph. Bielschowsky silver stain. This section shows slight pallor in the demyelinated area, but with relative axonal preservation. This is the core of the definition of a demyelinating disease. C) Multiple Sclerosis. Photomicrograph H&E High Power. This field shows a perivenular inflammatory cell infiltrate. This is associated with the breakdown of the blood-brain-barrier. The clinical hallmark of MS has always been a multiphasic illness with lesions separated in space (geographically dispersed within the CNS) and in time. The pathology and imaging are thus also varied -with multiple lesions identified in various states ranging from acute and symptomatic to chronic scars with/or without residual neurologic deficits (figure 1).
In the original descriptions of the histology of MS, the classic appearance included demyelination with preservation of axons. However, it is now well known that axonopathy is part of MS. Lesions are also not exclusively limited to the WM, but may also affect the gray matter of the cortex and deep nuclear gray matter -especially the thalamus. Inflammation is a consistent though variable feature of MS -and both macrophages and lymphocytes may be present (figure 2). It has been said that these cellular infiltrates may not occur with an intact blood-brain-barrier -and that an alteration in capillary permeability is a common feature of MS -causing the contrast enhancement seen on MR and CT images. On gross anatomic sections, the normal white color of the central "white matter" is produced by the reflection of light from myelinated nerve fibers. Loss of myelin creates an amber, tan, or brown discoloration -regardless of the cause of demyelination. Likewise, on MRI, the bright signal of WM on T1-weighted images -and corresponding darker signal seen on T2-are due to lipid in normal myelin. Loss the myelin, and the WM signal changes to reflect the water content, becoming bright on FLAIR and T2W images (figure 1). Characteristically in MS patients, there are multiple lesions that enhance variably based on the degree of inflammatory breakdown of the blood-brain-barrier. Acute and/or active MS plaques usually enhance for 3-6 weeks -and only rarely longer than six months. The lesions are usually periventricular, often small (< 1.5 cm.), and they may be nodular round or more characteristically ovoid and perpendicular to the ventricular margin (figure 1). The classic "Dawson's fingers" are regions of perivenular inflammation, near the lateral margins of the lateral ventricle -and having an orientation perpendicular to the ventricular surface -which is the same as orientation of the WM veins (figure 2). The undersurface of the corpus callosum is usually involved in the region where the septum pellucidum attaches -the "callososeptal" interface -easily seen on sagittal T2 FLAIR images ( figure 1B) .
Variants of Multiple Sclerosis
There are several important and generally recognized variants of multiple sclerosis: Schilder disease, Marburg variant, Balo concentric sclerosis, and Devic disease. The most interesting of these are Balo and Devic. Balo concentric sclerosis produces a very peculiar patter of large lesions with alternating concentric bands of inflammation and demyelination. This pattern is seen both in gross brain pathology as well as on imaging studies with CT and MR ( figure 3) .
Devic disease -acute demyelination most prominent or limited to the optic nerve and spinal cord -is also known as "Neuromyelitis Optica" or NMO. A protein marker has been identified. It has long been known that some patient with optic neuritis will develop classic MS -while others will not. A serum assay for the NMO protein has been developed by researchers at the Mayo clinic and may help delineate these patient groups.
Tumefactive Demyelination
Tumefactive demyelinating lesions (TDL) may or may not be related to MS or to other demyelination etiologies such as ADEM. TDL -by its original definition -presents on imaging a mass lesion suggesting neoplasm, less often an abscess. In the past, without recognizing the features that suggest TDL, the majority were diagnosed by biopsy or resection. Most cases of "tumefactive" demyelination may not actually have any mass-effect and do not displace nor distort normal structures. However, the presence of large (> 3 cm) lesions with peripheral enhancement on MR or CT often suggests tumor (figure 4). Features suggesting TDL include: lack of significant mass-effect and/or mass effect less than proportional to the size of the signal change; lack of surrounding vasogenic edema; and, enhancement that is discontinuous -forming an "incomplete" or "open-ring" sign (figure 4, 5). It must be emphasized that most demyelinating lesions with enhancement have a small rounded nodular pattern (like in MS), a large nodular pattern (ADEM), or show the incomplete ring/rim sign. Most helpful in using imaging for the differential diagnosis from neoplasms, is the "edge sign" -where the WM signal abnormality corresponds almost exactly with the edge of the enhancement ( figure 5) . This is quite different compared with metastatic neoplasm, gliomas, and abscesses -that are usually seen to have WM signal change of interstitial vasogenic edema that extends well "beyond the rim" of contrast enhancement. Some patients with TDL have a monophasic illness -suggesting a relationship to ADEM. Other patients presenting with TDL develop additional signs, symptoms, and imaging lesions more consistent with MS.
It is important to recognize the possibility of TDL and therefore avoid biopsy of and treatment for a nonexistent neoplasm.
Acute Disseminated Encephalomyelitis
Acute Disseminated Encephalomyelitis (ADEM) is most likely an immune mediated demyelinating process. It is most commonly seen after exposure to an infectious antigen -either through vaccination or after an infection. Patients typically present within two weeks of the antigenic stimulus with a rapidly progressing clinical course that usually responds well to steroids. Multiple WM lesions are typical of ADEM; and, these lesions are typically much larger than the small ovoid or nodular lesions characteristic of MS ( Figure 6 ). Also unlike MS, ADEM is almost always a monophasic and self-limited disease process.
Histologically, ADEM may appear very similar to MS ( figure 7) . There is a more aggressive variant of ADEM called Hurst disease or phenomenon that is associated with a fulminant and often fatal clinical course. These patients initially develop petechial bleeding in regions of active and often aggressive demyelination. These small hemorrhages may grow and/or coalesce into large hematomas.
Progressive Multifocal Leukoencephalopathy
Progressive Multifocal Leukoencephalopathy (PML) is now well-known to be an infectious demyelinating lesion caused by the JC virus. The JC virus, from the papova family, is named for John Cunningham, the patient from who the first samples were cultured. PML usually -but not exclusively -affects patients who are immune-suppressed for any of several reasons, including transplantation, because of HIV infection, or as a result of intercurrent chronic diseases (diabetes, tuberculosis, etc).
Lesions are characteristically larger, more peripheral, often subcortical, geographic, and multiple (figure 8). HIV associated PML typically spares the subcortical u-fibers, creating a clear-cut lesion margin against the unaffected gray matter. These lesions usually do not have visible mass effect nor contrast enhancement. When there is enhancement, it is usually at the edges of the lesions in a garland pattern. In the original early reports during the 1980s, PML was almost universally fatal after an illness of six to eight months. However, with highly aggressive anti-retroviral therapy (HARRT) PML is less frequent and long-term survival has become more common.
Osmotic Myelinolysis and Toxic Myelinolysis
Originally described as demyelination limited to the central pons (Central Pontine Myelinolysis -CPM) this disorder has frequent and prominent extrapontine lesions. As the name suggests, the putative cause is related to osmotic flux changes. CPM was originally reported in patients with severe hyponatremia (serum sodium <125) who had rapid correction using hypertonic saline (4%).
However, that may be an oversimplification and there is some association with malnutrition, vitamin deficiency, and alcoholism. Classically there are lesions of demyelination in the central pons, with characteris-tic sparing of the tissue around the periphery (figure 9, 10). Patients may also develop lesions in the supratentorial white-matter -including the corpus callosum. Some have theorized that the demyelination is related to local conditions in regions of the brain where white matter and gray matter are in close proximity or are interleaved -like the WM bundles around the cranial nerve nuclei in the brainstem.
There are several types of demyelination that are re-lated to specific inciting conditions or toxic exposures. These include vitamin B12 deficiency (and the related N20 toxicity) and heroin vapor intoxication. B12 deficiency and nitrous oxide exposure commonly affect the spinal cord, with posterior column degeneration. This is typically a chronic process. Smoking heroin and inhaling the heroin vapors is called "Chasing the Dragon". This produces a suggestive pattern of demyelination involving the posterior limb of the internal capsule. There is extensive central demyelination of the pons with preservation of myelin in a rim around the periphery of the brainstem. This is the classic appearance originally described as "central pontine myelinolysis" or CPM. B) Osmotic myelinolysis. Axial FLAIR MR There is extensive central demyelination of the pons with preservation of myelin in a rim around the periphery of the brainstem. This is the classic appearance originally described as "central pontine myelinolysis" or CPM.
Summary and Conclusion
White matter diseases are varied and complex, with significant overlap in clinical presentation, neuroimaging, and pathology. Careful clinical evaluation, combined with analysis of the imaging patterns, may provide essential information that guides patient management and therapy. One of the most important takeaway concepts is the correct differential diagnosis of large and/or aggressive demyelinating lesions that may mimic a neoplastic process. J.G. Smirniotopoulos, MD Department of Radiology Uniformed Services University 4301 Jones Bridge Road Bethesda, MD 20814 USA E-mail: james-smirnio@usuhs.mil
